常用名 | Oprozomib (ONX 0912) | CAS号 | 935888-69-0 |
---|---|---|---|
价格 | 纯度 | 98.0% | |
备货期 | 10天 | 库存 | 现货 |
产品详情(用途,包装等)
用途: Oprozomib (ONX 0912; PR047) is an orally bioavailable inhibitor for CT-L activity of 20S proteasome β5/LMP7 with IC50 of 36 nM/82 nM.IC50 value: 36 nM/82 nM(20S proteasome β5/LMP7) [1]Target: 20S proteasomeThe anti-MM activity of Oprozomib is associated with activation of caspase-8, caspase-9, caspase-3, and PARP, as well as inhibition of migration of MM cells and angiogenesis. Oprozomib is demonstrated an absolute bioavailability of up to 39% in rodents and dogs. It is well tolerated with repeated oral administration at doses resulting in >80% proteasome inhibition in most tissues and elicited an antitumor response in multiple human tumor xenograft and mouse syngeneic models. 物理化学性质: CAS号:935888-69-0 常用中文名:Oprozomib (ONX 0912) 常用英文名:Oprozomib (ONX 0912) 分子式:C25H32N4O7S 分子量:532.609 密度:1.3±0.1 g/cm3 沸点:849.9±65.0 °C at 760 mmHg 熔点:N/A 闪点:467.8±34.3 °C 储存条件:-20℃ |